Home | Welcome to Contract Pharma   
Last Updated Tuesday, July 29 2014
Print

Search Results for 'Financial Report: AMRI 3Q'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

AMRI
By James Grabowski, Manager, Sales Operations
AMRI is a global contract research and manufacturing organization offering integrated drug discovery, development, and manufacturing services. AMRI's experience, a track record of success and locations in North America, Europe and Asia provide ou… Read More »
Published November 6, 2013
Contract revenue up 16% in the quarter Read More »
Published November 6, 2012
Large-scale manufacturing revenue up 14% Read More »
Published November 7, 2008
AMRI 3Q Revenues: $61.4 million (+29%) 3Q Earnings: $7.0 million (+250%) YTD Revenues: $172.9 million (+19%) YTD Earnings: $17.4 million (+78%) Comments: Total contract revenue for the quarter was $54.1 million (+30%). Discovery Servi… Read More »
By Bob Muschert, Global Sales & Business Development Director
By Jerome BESSE, CEO
By Tom Patnaik, Director of Sales & MArketing
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On